Clinical Trials

December 03, 2024

Read the latest findings from Dr. Baron and her team at Huntsman Cancer Institute on the efficacy of BR versus R-CHOP in treating follicular lymphoma.

November 19, 2024

Learn how golcadomide in combination with R-CHOP helped DLBCL patients in a phase 1 clinical trial.

October 01, 2024

Understanding CAR T-Cell Therapy and the Armored CAR T-Cell Trial

September 30, 2024

Learn about clinical trials to open the door to accessing innovative cancer treatments.

July 23, 2024

Learn about bendamustine, a treatment option for follicular lymphoma. Discover how it works, potential side effects, and important safety considerations.

May 20, 2024

Columvi (Glofitamab) To Treat Relapsed Or Refractory DLBCL, new treatment option for DLBCL, Clinical Trial for DLBCL

April 25, 2024

New study shows Brentuximab Vedotin combined therapy effective for relapsed DLBCL (lymphoma). Learn about ADCETRIS and its side effects.

October 16, 2023

Dr. Gunjan L. Shah and her team at MSK in NY are conducting a clinical trial to reverse T-cell exhaustion by pairing antioxidants alongside CAR T-cell therapy.

October 10, 2023

A non-chemo treatment combination of zanubrutinib and obinutuzumab evaluated in the ROSEWOOD study showed promising treatment results.

October 08, 2023

The Food and Drug Administration (FDA) approved Columvi (glofitamab-gxbm) to treat adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL)